Correlation Engine 2.0
Clear Search sequence regions

  • acetate (1)
  • DGA1 (1)
  • diacylglycerol (1)
  • hmg coa (1)
  • HMG1 (2)
  • research (1)
  • yarrowia (1)
  • yarrowia lipolytica (2)
  • Sizes of these terms reflect their relevance to your search.

    The aim of this present research is to enhance the squalene production in Yarrowia lipolytica using pathway engineering and bioprocess engineering. Firstly, to improve the production of squalene, the endogenous HMG-CoA reductase (HMG1) was overexpressed in Y. lipolytica to yield 208.88 mg/L squalene. Secondly, the HMG1 and diacylglycerol acyltranferase (DGA1) were co-overexpressed, the derived recombinant Y. lipolytica SQ-1 strain produced 439.14 mg/L of squalene. Thirdly, by optimizing the fermentation medium, the improved titer of squalene with 514.34 mg/L was obtained by the engineered strain SQ-1 grown on YPD-80 medium. Finally, by optimizing the addition concentrations of acetate, citrate and terbinafine, the 731.18 mg/L squalene was produced in the engineered strain SQ-1 with the addition of 0.5 mg/L terbinafine. This work describes the highest reported squalene titer in Y. lipolytica to date. This study will provide the foundation for further engineering Y. lipolytica capable of cost-efficiently producing squalene. Copyright © 2020. Published by Elsevier Ltd.


    Wen-Yan Tang, Dong-Ping Wang, Yun Tian, Xiao Fan, Chong Wang, Xiang-Yang Lu, Pei-Wang Li, Xiao-Jun Ji, Hu-Hu Liu. Metabolic engineering of Yarrowia lipolytica for improving squalene production. Bioresource technology. 2021 Mar;323:124652

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33421835

    View Full Text